424 related articles for article (PubMed ID: 11793011)
21. Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11.
Flotho C; Steinemann D; Mullighan CG; Neale G; Mayer K; Kratz CP; Schlegelberger B; Downing JR; Niemeyer CM
Oncogene; 2007 Aug; 26(39):5816-21. PubMed ID: 17353900
[TBL] [Abstract][Full Text] [Related]
22. A mouse embryonic stem cell model of Schwann cell differentiation for studies of the role of neurofibromatosis type 1 in Schwann cell development and tumor formation.
Roth TM; Ramamurthy P; Ebisu F; Lisak RP; Bealmear BM; Barald KF
Glia; 2007 Aug; 55(11):1123-33. PubMed ID: 17597122
[TBL] [Abstract][Full Text] [Related]
23. Recent developments in neurofibromatosis type 1.
Lee MJ; Stephenson DA
Curr Opin Neurol; 2007 Apr; 20(2):135-41. PubMed ID: 17351482
[TBL] [Abstract][Full Text] [Related]
24. Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1.
Dilworth JT; Kraniak JM; Wojtkowiak JW; Gibbs RA; Borch RF; Tainsky MA; Reiners JJ; Mattingly RR
Biochem Pharmacol; 2006 Nov; 72(11):1485-92. PubMed ID: 16797490
[TBL] [Abstract][Full Text] [Related]
25. Hyperactive Ras as a therapeutic target in neurofibromatosis type 1.
Weiss B; Bollag G; Shannon K
Am J Med Genet; 1999 Mar; 89(1):14-22. PubMed ID: 10469432
[TBL] [Abstract][Full Text] [Related]
26. Modeling neurofibromatosis type 1 tumors in the mouse for therapeutic intervention.
Parada LF; Kwon CH; Zhu Y
Cold Spring Harb Symp Quant Biol; 2005; 70():173-6. PubMed ID: 16869751
[TBL] [Abstract][Full Text] [Related]
27. Ras dependent paracrine secretion of osteopontin by Nf1+/- osteoblasts promote osteoclast activation in a neurofibromatosis type I murine model.
Li H; Liu Y; Zhang Q; Jing Y; Chen S; Song Z; Yan J; Li Y; Wu X; Zhang X; Zhang Y; Case J; Yu M; Ingram DA; Yang FC
Pediatr Res; 2009 Jun; 65(6):613-8. PubMed ID: 19247213
[TBL] [Abstract][Full Text] [Related]
28. Restored plasticity in a mouse model of neurofibromatosis type 1 via inhibition of hyperactive ERK and CREB.
Guilding C; McNair K; Stone TW; Morris BJ
Eur J Neurosci; 2007 Jan; 25(1):99-105. PubMed ID: 17241271
[TBL] [Abstract][Full Text] [Related]
29. Impairment of Procedural Learning and Motor Intracortical Inhibition in Neurofibromatosis Type 1 Patients.
Zimerman M; Wessel MJ; Timmermann JE; Granström S; Gerloff C; Mautner VF; Hummel FC
EBioMedicine; 2015 Oct; 2(10):1430-7. PubMed ID: 26629537
[TBL] [Abstract][Full Text] [Related]
30. Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations.
Pros E; Fernández-Rodríguez J; Canet B; Benito L; Sánchez A; Benavides A; Ramos FJ; López-Ariztegui MA; Capellá G; Blanco I; Serra E; Lázaro C
Hum Mutat; 2009 Mar; 30(3):454-62. PubMed ID: 19241459
[TBL] [Abstract][Full Text] [Related]
31. Neurofibromin regulates corticostriatal inhibitory networks during working memory performance.
Shilyansky C; Karlsgodt KH; Cummings DM; Sidiropoulou K; Hardt M; James AS; Ehninger D; Bearden CE; Poirazi P; Jentsch JD; Cannon TD; Levine MS; Silva AJ
Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13141-6. PubMed ID: 20624961
[TBL] [Abstract][Full Text] [Related]
32. Adult neurological function following neonatal hypoxia-ischemia in a mouse model of the term neonate: water maze performance is dependent on separable cognitive and motor components.
McAuliffe JJ; Miles L; Vorhees CV
Brain Res; 2006 Nov; 1118(1):208-21. PubMed ID: 16997287
[TBL] [Abstract][Full Text] [Related]
33. Structural and biochemical consequences of NF1 associated nontruncating mutations in the Sec14-PH module of neurofibromin.
Welti S; Kühn S; D'Angelo I; Brügger B; Kaufmann D; Scheffzek K
Hum Mutat; 2011 Feb; 32(2):191-7. PubMed ID: 21089070
[TBL] [Abstract][Full Text] [Related]
34. Sensory neurons from Nf1 haploinsufficient mice exhibit increased excitability.
Wang Y; Nicol GD; Clapp DW; Hingtgen CM
J Neurophysiol; 2005 Dec; 94(6):3670-6. PubMed ID: 16093333
[TBL] [Abstract][Full Text] [Related]
35. Sensitization of Ion Channels Contributes to Central and Peripheral Dysfunction in Neurofibromatosis Type 1.
Moutal A; Dustrude ET; Khanna R
Mol Neurobiol; 2017 Jul; 54(5):3342-3349. PubMed ID: 27167129
[TBL] [Abstract][Full Text] [Related]
36. [Cognitive dysfunction and emotional disturbances in children with neurofibromatosis type one (Recklinghausen's disease). Review of the literature].
Trzcińska M; Borkowska A
Psychiatr Pol; 2005; 39(2):371-81. PubMed ID: 15881631
[TBL] [Abstract][Full Text] [Related]
37. Neurofibromatosis type 1 alternative splicing is a key regulator of Ras/ERK signaling and learning behaviors in mice.
Nguyen HT; Hinman MN; Guo X; Sharma A; Arakawa H; Luo G; Lou H
Hum Mol Genet; 2017 Oct; 26(19):3797-3807. PubMed ID: 28934393
[TBL] [Abstract][Full Text] [Related]
38. Forebrain-specific knockout of B-raf kinase leads to deficits in hippocampal long-term potentiation, learning, and memory.
Chen AP; Ohno M; Giese KP; Kühn R; Chen RL; Silva AJ
J Neurosci Res; 2006 Jan; 83(1):28-38. PubMed ID: 16342120
[TBL] [Abstract][Full Text] [Related]
39. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1.
Jacks T; Shih TS; Schmitt EM; Bronson RT; Bernards A; Weinberg RA
Nat Genet; 1994 Jul; 7(3):353-61. PubMed ID: 7920653
[TBL] [Abstract][Full Text] [Related]
40. Modulation of cAMP and ras signaling pathways improves distinct behavioral deficits in a zebrafish model of neurofibromatosis type 1.
Wolman MA; de Groh ED; McBride SM; Jongens TA; Granato M; Epstein JA
Cell Rep; 2014 Sep; 8(5):1265-70. PubMed ID: 25176649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
